最近审阅: 25 十月 2020
最近更新: 28 三月 2018

小结

定义

病史和体格检查

关键诊断因素

  • 存在危险因素
  • 疼痛(前葡萄膜炎)
  • 视力下降
  • 粘连
  • 前房闪辉
  • 角膜后沉着物

其他诊断因素

  • 流泪
  • 畏光
  • 飞蚊症
  • 红眼但无分泌物
  • 瞳孔缩小或无反应
  • 眼压降低
  • 视网膜渗出和水肿、视神经水肿
  • 视网膜血管鞘
  • 黄斑水肿
  • 视盘肿胀
  • 视网膜出血
  • 睫状充血
  • 角膜水肿
  • 白内障

危险因素

  • 关节、肠道或皮肤的炎症性疾病
  • 人类白细胞抗原-B27 (human leucocyte antigen-B27, HLA-B27) 检测阳性
  • 眼部外伤
  • 年龄在 30-40 岁之间

诊断性检查

需考虑的检查

  • 全血细胞计数 (FBC)
  • 红细胞沉降率 (ESR)
  • C 反应蛋白 (CRP)
  • FTA-ABS、VDRL 以及 RPR
  • 血清 ACE 水平
  • 抗核抗体
  • HLA-B27
  • 抗伯氏疏螺旋体抗体滴度
  • 纯化蛋白衍生物 (purified protein derivative, PPD) 皮试
  • 胞浆型抗中性粒细胞胞浆抗体 (c-ANCA)
  • 核周型抗中性粒细胞胞浆抗体 (p-ANCA)
  • C3 和 C4
  • 抗双链 DNA 抗体(抗-dsDNA)
  • 类风湿因子
  • 抗环瓜氨酸多肽(抗 CCP)抗体
  • 汉赛巴尔通体滴度
  • 血清弓形虫抗体滴度
  • 其他 HLA 抗原
  • 生化筛查
  • 胸部 X 线检查 (CXR)
更多 需考虑的检查

治疗流程

撰稿人

President

Connecticut Uveitis Foundation

Associate Clinical Professor

Yale University

New Haven

Eye Disease Consultants

Hartford

CT

利益声明

JJH declares that he has no competing interests.

Uveitis and Retina Specialist

Medical Eye Center of New Hampshire

Manchester

NH

利益声明

ME declares that he has no competing interests.

Dr John J. Huang and Dr Max Elia would like to gratefully acknowledge Dr Richard Gale, Dr Zsolt Varga, Dr Victor L. Perez, and Dr Carlos A. Medina, the previous contributors to this monograph. RG, ZV, VLP, and CAM declare that they have no competing interests.

同行评议者展开全部内容

Assistant Professor

Ophthalmology

Mount Sinai Hospital

New York

NY

利益声明

JA declares that she has no competing interests.

Director of Ophthalmology

Alfred Hospital

Melbourne

Australia

利益声明

AJH has been reimbursed by Novartis, the manufacturer of Lucentis, for lecture fees. AJH's employer, the Alfred Hospital, has received research funding from Novartis, the manufacturer of Lucentis, and from Bayer, the manufacturer of Eylea.

Chairman

Department of Ophthalmology

The University of Texas Health Science Center at San Antonio

San Antonio

TX

利益声明

DAJ declares that he has no competing interests.

内容使用需遵循免责声明